Integrated Hemophilia Patient Care via a National Network of Care Centers in the United States: A Model for Rare Coagulation Disorders
Leonard A Valentino,Judith R Baker,Regina Butler,Miguel Escobar,Neil Frick,Susan Karp,Kollet Koulianos,Susan Lattimore,Diane Nugent,Joseph N Pugliese,Michael Recht,Mark T Reding,Michelle Rice,Constance B Thibodeaux,Mark Skinner
DOI: https://doi.org/10.2147/JBM.S325031
2021-10-22
Journal of Blood Medicine
Abstract:Leonard A Valentino, 1, 2 Judith R Baker, 3 Regina Butler, 4 Miguel Escobar, 5 Neil Frick, 1 Susan Karp, 6 Kollet Koulianos, 1 Susan Lattimore, 7 Diane Nugent, 3 Joseph N Pugliese, 8 Michael Recht, 7, 9 Mark T Reding, 10 Michelle Rice, 1 Constance B Thibodeaux, 11 Mark Skinner 12, 13 1 National Hemophilia Foundation, New York, NY, USA; 2 Departments of Internal Medicine and Pediatrics, Rush University, Chicago, IL, USA; 3 Center for Inherited Blood Disorders, Orange, CA, USA; 4 Children's Hospital of Philadelphia, Philadelphia, PA, USA; 5 Department of Internal Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA; 6 University of California, San Francisco, San Francisco, CA, USA; 7 Department of Pediatrics, Oregon Health & Science University, Portland, OR, USA; 8 Hemophilia Alliance, Lansdale, PA, USA; 9 American Thrombosis and Hemostasis Network, Rochester, NY, USA; 10 Department of Internal Medicine, University of Minnesota Medical Center, Minneapolis, MN, USA; 11 Departments of Internal Medicine and Pediatrics, Hemophilia Center, Tulane University School of Medicine, New Orleans, LA, USA; 12 Institute for Policy Advancement Ltd, Washington, DC, USA; 13 Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada Correspondence: Leonard A Valentino National Hemophilia Foundation, 7 Penn Plaza Suite 1204, New York, NY, 10001, USA Tel +1 212 328 3700 Fax +1 212 328 3777 Email Rare, chronic diseases such as hemophilia and other congenital coagulation disorders require coordinated delivery of services for optimal outcomes. Hemophilia Treatment Centers (HTCs) are specialized, multidisciplinary health-care centers providing team-based care to meet the physical, psychosocial, and emotional needs of people with hemophilia (PWH) and may serve as a model for other rare coagulation disorders. Health-care purchasers, as well as the general medical community, may not appreciate the breadth and quality of services provided by HTCs. They exemplify the acculturalization and actualization of integrated care by providing comprehensive diagnostic and treatment services that reduce morbidity, mortality, avoidable emergency room visits, hospitalizations, and overall costs, while promoting a longer lifespan and improved patient functioning and outcomes. This is accomplished by a team-based approach relying upon a shared decision-making model to effectively prevent complications and manage symptoms in PWH, who are dependent on high-cost treatments. This article provides a concise yet comprehensive description of the core components of an HTC and the regional and national networks in the United States, which together achieve their incomparable value for all stakeholders. Keywords: hemophilia, coagulation disorders, integrated care, patient-centered care, health-care delivery network, multidisciplinary Hemophilia Treatment Centers (HTCs) and the regional and national network to which they each belong deliver integrated, patient-centered care that reduces morbidity, mortality, and overall costs, while promoting a longer lifespan and improved outcomes. However, a comprehensive presentation of the HTC Network of care in the United States has not been published since 2005. During the intervening years, there have been dramatic changes in the diagnosis and treatment of hemophilia and other rare coagulation disorders and rapid evolution in the importance of patient-centered, integrated, value-oriented care. For example, there is more widespread acceptance of prophylaxis as the standard of care for severe hemophilia and there are many more factor and non-factor therapies available for patients to consider. In addition, there has been a dramatic shift in the patient populations served by HTCs, including many more middle-aged and older adults, women, and people with other rare coagulation disorders. Moreover, there are new organizations, such as the American Thrombosis and Hemostasis Network (ATHN), that did not exist in 2005 and which now play a central role, and advances in information technology and telemedicine that have revolutionized the ways in which care is provided. This article was written to help inform the medical and public health communities about the inner workings of a complex but highly coordinated approach to delivery of health-care services to this unique population, and to advance widespread recognition of the benefits of this model of care to ensure that sufficient funding and support continues into the future. Hemophilia -Abstract Truncated-